MedPath

Benefit of Systematic Proposition of Nicotine Substitution for Patients Undergoing Surgery

Not Applicable
Terminated
Conditions
Smoking Cessation
Interventions
Other: NRT proposition and exhaled CO measurement
Registration Number
NCT04572646
Lead Sponsor
Groupe Hospitalier Mutualiste de Grenoble
Brief Summary

Smoking is associated with a higher rate of surgical complications. For example, in orthopedics, the risk of complications is 31% in smokers against 5% in non-smokers. The management of this addiction is recommended and particularly interesting in scheduled surgery, because it allows smoking cessation well before the procedure. However, for patients who cannot consider this smoking cessation, the mere information of the risk cannot be sufficient and a real strategy must be constructed and evaluated.

Currently, studies results indicate that a patient reducing the number of smoked cigarettes will unconsciously modify their smoking behaviour to obtain the usual nicotine level, this effect is called self-titration. Conversely, nicotine replacement while continuing consumption could induce an improvement in smoking behaviour, therefore less intoxication which would be beneficial in terms of reduction of post-operative complications. This study seeks to assess the effectiveness of a systematic proposition of nicotine replacement therapy (NRT) in regular smokers. Tobacco addiction specialists have demonstrated that intoxication and dependence are well correlated with the exhaled carbon monoxide (CO) level, so this measurement will be used in addition to the patient's interview.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Patient who smokes at least one cigarette or cannabis joint per day, every day
  • Patient received for nurse consultation at least 48 hours before surgery
  • Patient planned to undergo surgery, with entry the day of surgery and 1 day of post-operative hospitalisation
  • Patient in physical capacity and willing to undergo exhaled carbon monoxide measurement
  • For patients with one of the following chronic diseases: diabetes, Chronic Obstructive Pulmonary Disease, glucose intolerance, hemolytic anemia, asthma and dilation of the bronchi, these diseases must be stable
  • Signature of the specific study informed consent
  • Patient affiliated or beneficiary of social security system
Exclusion Criteria
  • Inability to submit to study follow-up for geographic, social or psychological reasons
  • Patient already included in an interventional clinical research protocol
  • Patients protected by French law from clinical research inclusion (pregnant, in labour, breastfeeding, legally protected, under judiciary or administrative liberty deprivation)
  • Patient using nicotine substitutes before the nurse consultation
  • Alcohol consumption six hours before the exhaled carbon monoxide measurement

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
NRT proposition and exhaled CO measurementNRT proposition and exhaled CO measurement-
Primary Outcome Measures
NameTimeMethod
Efficacy of a systematic proposition of nicotine replacement therapy, regardless of the intention to quit Change in exhaled carbon monoxide level between the two measurements, assessed by a carbon monoxide breath monitorAt inclusion, and before surgery
Secondary Outcome Measures
NameTimeMethod
Effect of nicotine replacement therapy on the dose of analgesics administratedAt inclusion, before surgery, and 2 days after surgery
Effect of nicotine replacement therapy on the type of analgesics administratedAt inclusion, before surgery, and 2 days after surgery
Effect of nicotine replacement therapy on the duration of analgesics administratedAt inclusion, before surgery, and 2 days after surgery
Efficacy of a systematic proposition of nicotine replacement therapy, depending on the intention to quit Change in exhaled carbon monoxide level between the two measurements, assessed by a carbon monoxide breath monitorAt inclusion, and before surgery

Subgroup analysis of the primary endpoint according to predefined groups

Number of smoking cessations2 days after surgery
Number of patients who refuse nicotine replacement therapyAt inclusion

Trial Locations

Locations (1)

Groupe hospitalier Mutualiste de Grenoble

🇫🇷

Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath